Di Wu

Dr. Di Wu


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 December 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
HMHongxia Ma
Hongxia Ma
KWKe Wu
Ke Wu
FDFei-Hong Dong
Fei-Hong Dong
BCBing-Kun Cai
Bing-Kun Cai
DWDi Wu
Di Wu
HLHuiyi Lv
Huiyi Lv
Sodium-glucose co-transport protein 2 (SGLT2) inhibitors, a novel category of oral hypoglycemic agents, offer a promising outlook for individuals experiencing heart failure with reduced ejection fraction. Evidence is emerging that highlights their potential in alleviating myocardial fibrosis and oxidative stress. However, the precise mechanisms through which SGLT2 inhibitors influence myocardial fibrosis induced by angiotensin II (Ang II) or transforming growth factor-β1 (TGF-β1) are not fully understood. This study aims to explore the intricate mechanisms by which SGLT2 inhibitors ameliorate myocardial fibrosis, particularly focusing on the nuanced interplay within the SIRT6 signaling pathway. Primary cardiac fibroblasts were isolated from the hearts of 1-3-day-old neonatal KM mice, were stimulated with Ang II or TGF-β1 to establish an in vitro model of myocardial fibrosis. Treatment with 10 µM Empagliflozin (EMPA) and Dapagliflozin (DAPA) significantly curtailed the proliferation of cardiac fibroblasts, substantially reduced collagen expression induced by Ang II/TGF-β1, and mitigated the phenotypic transformation and oxidative stress response. SIRT6, which is closely associated with myocardial fibrosis, demonstrated that the suppression its expression attenuated the protective effects of EMPA and DAPA against myocardial fibrosis and oxidative stress. Our findings suggest that SGLT2 inhibitors markedly decrease the Ang II/TGF-β1-induced transformation of cardiac fibroblasts to a myofibroblast phenotype by upregulating SIRT6 protein expression, thereby inhibiting oxidative stress and ameliorating myocardial fibrosis.

7 February 2022 in Acta Pharmacologica Sinica
Verified
Journal Article
Open access
PDF file
DWDi Wu
Di Wu
DZDan Zhao
Dan Zhao
DHDi Huang
Di Huang
XSXun Sun
Xun Sun
KLKe-Xin Li
Ke-Xin Li
BLBai-yan Li
Bai-yan Li
Recent studies suggest that melatonin (Mel) plays an important role in the regulation of blood pressure (BP) via the aortic baroreflex pathway. In this study, we investigated the interaction between the baroreflex afferent pathway and Mel-mediated BP regulation in rats under physiological and hypertensive conditions. Mel (0.1, 0.3, and 1.0 mg/mL) was microinjected into the nodose ganglia (NG) of rats. We showed that Mel-induced reduction of mean arterial pressure in female rats was significantly greater than that in male and in ovariectomized rats under physiological condition. Consistently, the expression of Mel receptors (MTNRs) in the NG of female rats was significantly higher than that of males. In L-NAME-induced hypertensive and spontaneously hypertensive rat models, MTNRs were upregulated in males but downregulated in female models. Interestingly, Mel-induced BP reduction was found in male hypertensive models. In whole-cell recording from identified baroreceptor neurons (BRNs) in female rats, we found that Mel (0.1 μM) significantly increased the excitability of a female-specific subpopulation of Ah-type BRNs by increasing the Nav1.9 current density via a PKC-mediated pathway. Similar results were observed in baroreceptive neurons of the nucleus tractus solitarius, showing the facilitation of spontaneous and evoked excitatory post-synaptic currents in Ah-type neurons. Collectively, this study reveals the estrogen-dependent effect of Mel/MTNRs under physiological and hypertensive conditions is mainly mediated by Ah-type BRNs, which may provide new theoretical basis and strategies for the gender-specific anti-hypertensive treatment in clinical practice.

1 January 2024 in International Journal of Medical Sciences
Verified
Journal Article
Open access
PDF file
SGShan Gao
Shan Gao
YLYing Li
Ying Li
MLMei-Ming Liu
Mei-Ming Liu
XXXue Xiong
Xue Xiong
CCChang-Peng Cui
Chang-Peng Cui
BLBai-yan Li
Bai-yan Li
Cardiac hypertrophy is the most prevalent compensatory heart disease that ultimately leads to spontaneous heart failure. Mounting evidence suggests that microRNAs (miRs) and endogenous hydrogen sulfide (H2S) play a crucial role in the regulation of cardiac hypertrophy. In this study, we aimed to investigate whether inhibition of miR-27a could protect against cardiac hypertrophy by modulating H2S signaling. We established a model of cardiac hypertrophy by obtaining hypertrophic tissue from mice subjected to transverse aortic constriction (TAC) and from cells treated with angiotensin-II. Molecular alterations in the myocardium were quantified using quantitative real time PCR (qRT-PCR), Western blotting, and ELISA. Morphological changes were characterized by hematoxylin and eosin (HE) staining and Masson's trichrome staining. Functional myocardial changes were assessed using echocardiography. Our results demonstrated that miR-27a levels were elevated, while H2S levels were reduced in TAC mice and myocardial hypertrophy. Further luciferase and target scan assays confirmed that cystathionine-γ-lyase (CSE) was a direct target of miR-27a and was negatively regulated by it. Notably, enhancement of H2S expression in the heart was observed in mice injected with recombinant adeno-associated virus vector 9 (rAAV9)-anti-miR-27a and in cells transfected with a miR-27a inhibitor during cardiac hypertrophy. However, this effect was abolished by co-transfection with CSE siRNA and the miR-27a inhibitor. Conversely, injecting rAAV9-miR-27a yielded opposite results. Interestingly, our findings demonstrated that glucagon-like peptide-1 (GLP-1) agonists could mitigate myocardial damage by down-regulating miR-27a and up-regulating CSE. In summary, our study suggests that inhibition of miR-27a holds therapeutic promise for the treatment of cardiac hypertrophy by increasing H2S levels. Furthermore, our findings unveil a novel mechanism of GLP-1 agonists involving the miR-27a/H2S pathway in the management of cardiac hypertrophy.

4 July 2025 in The FASEB Journal
Verified
Journal Article
Closed access
KWKe Wu
Ke Wu
HMHong‐Xia Ma
Hong‐Xia Ma
ZLZhong‐Yan Li
Zhong‐Yan Li
YLYan Li
Yan Li
DWDi Wu
Di Wu
HLHui‐Yi Lu
Hui‐Yi Lu

16 October 2024 in Biomolecules
Verified
Journal Article
Open access
PDF file
YXYin-Zhi Xu
Yin-Zhi Xu
ZXZhao-Yuan Xu
Zhao-Yuan Xu
HFHui-Xiao Fu
Hui-Xiao Fu
MYMao Yue
Mao Yue
JLJia-Qun Li
Jia-Qun Li
BLBai-yan Li
Bai-yan Li
Multi-drug therapies are common in cardiovascular disease intervention; however, io channel/pump coordination has not been tested electrophysiologically. Apparently, inward currents were not elicited by Yoda1/10 nM or Dobutamine/100 nM alone in Ah-type baroreceptor neurons, but were by their combination. To verify this, electroneurography and the whole-cell patch-clamp technique were performed. The results showed that Ah- and C-volley were dramatically increased by the combination at 0.5 V and 5 V, in contrast to A-volley, as consistent with repetitive discharge elicited by step and ramp with markedly reduced current injection/stimulus intensity. Notably, a frequency-dependent action potential (AP) duration was increased with Iberiotoxin-sensitive K+ component. Furthermore, an increased peak in AP measured in phase plots suggested enhanced Na+ influx, cytoplasmic Ca2+ accumulation through reverse mode of Na+/Ca2+ exchanger, and, consequently, functional KCa1.1 up-regulation. Strikingly, the Yoda1- or Dbtm-mediated small/transient Na+/K+-pump currents were robustly increased by their combination, implying a quick ion equilibration that may also be synchronized by hyperpolarization-induced voltage-sag, enabling faster repetitive firing. These novel findings demonstrate multi-channel/pump collaboration together to integrate neurotransmission at the cellular level for baroreflex, providing an afferent explanation in sexual dimorphic blood pressure regulation, and raising the caution regarding the individual drug concentration in multi-drug therapies to optimize efficacy and minimize toxicity.

3 May 2026 in Acta Physiologica
Verified
Journal Article
Open access
PDF file
ZJZhang Jing‐Ran
Zhang Jing‐Ran
FHFu Hui‐Xiao
Fu Hui‐Xiao
LXLi Xing‐Yu
Li Xing‐Yu
ZHZhang Hong‐Fei
Zhang Hong‐Fei
DTDou Tian‐Min
Dou Tian‐Min
DWDi Wu
Di Wu
Aim: To investigate how tetrodotoxin‐sensitive (TTX‐S) and tetrodotoxin‐resistant (TTX‐R) Na + channels coordinately fine‐tune action potential (AP) depolarization and firing capability in rat nodose visceral sensory neurons. Methods: APs were recorded by ruptured‐patch current clamp in unmyelinated C‐type and myelinated Ah‐type neurons from isolated and sliced nodose ganglia. Voltage derivatives and displacement current phase plots were used to determine the kick‐in voltage of TTX‐R following TTX‐S activation. Myelinated A‐type neurons, which express TTX‐S exclusively, served as a model for dynamic current‐clamp (DCC) simulation, in which gNa0 (TTX‐S) and gNa1 (TTX‐R) were injected separately or in combination. Results: Voltage derivatives and phase plots revealed a biphasic upstroke in C‐ and Ah‐type neurons, indicating sequential TTX‐S then TTX‐R activation. The TTX‐R kick‐in voltage was more negative in Ah‐type than in C‐type neurons and was strongly inversely correlated with the maximal upstroke velocity. DCC faithfully reproduced both AP types; TTX‐R reactivation generated the C‐type repolarization hump, and AP peak was preserved through proportional gNa0/gNa1 compensation. Increasing the integrated step size of gNa1 delayed TTX‐R recruitment, reduced the second Na + peak, and progressively impaired repetitive firing, whereas the TTX‐S peak remained unchanged. Conclusion: TTX‐S and TTX‐R Na + channels coordinate AP depolarization sequentially and compensatorily: TTX‐S initiates the upstroke, whereas TTX‐R is recruited later and reactivates during repolarization to constrain firing frequency. Combining patch‐clamp with DCC simulation provides novel insight into visceral sensory neuron excitability.